The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease

BACKGROUND: Chronic liver disease (CLD) is usually asymptomatic but earlier detection is critical to permit life-saving interventions for those at risk due to high alcohol consumption and increased body mass index (BMI). The aim of this study was to estimate the association between the Enhanced Live...

Descripción completa

Detalles Bibliográficos
Autores principales: Trembling, Paul M., Apostolidou, Sophia, Gentry-Maharaj, Aleksandra, Parkes, Julie, Ryan, Andy, Tanwar, Sudeep, Burnell, Matthew, Harris, Scott, Menon, Usha, Rosenberg, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158048/
https://www.ncbi.nlm.nih.gov/pubmed/32293289
http://dx.doi.org/10.1186/s12876-020-01251-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158048/
https://www.ncbi.nlm.nih.gov/pubmed/32293289
http://dx.doi.org/10.1186/s12876-020-01251-w

Ejemplares similares